Your browser doesn't support javascript.
loading
Recent Improvement in the Long-term Survival of Breast Cancer Patients by Age and Stage in Japan.
Yoshimura, Akiyo; Ito, Hidemi; Nishino, Yoshikazu; Hattori, Masakazu; Matsuda, Tomohiro; Miyashiro, Isao; Nakayama, Tomio; Iwata, Hiroji; Matsuo, Keitaro; Tanaka, Hideo; Ito, Yuri.
Afiliação
  • Yoshimura A; Division of Molecular and Clinical Epidemiology, Aichi Cancer Research Institute.
  • Ito H; Department of Breast Oncology, Aichi Cancer Center Hospital.
  • Nishino Y; Department of Epidemiology, Nagoya University Graduate School of Medicine.
  • Hattori M; Division of Molecular and Clinical Epidemiology, Aichi Cancer Research Institute.
  • Matsuda T; Department of Epidemiology, Nagoya University Graduate School of Medicine.
  • Miyashiro I; Division of Epidemiology & Prevention, Aichi Cancer Research Institute.
  • Nakayama T; Department of Epidemiology and Public Health, Kanazawa Medical University.
  • Iwata H; Department of Cancer Therapy Center, Fukui Prefectural Hospital.
  • Matsuo K; Cancer Information Services and Surveillance Division, Center for Cancer Control and Information Services, National Cancer Center.
  • Tanaka H; Department of Cancer Strategy, Cancer Control Center, Osaka International Cancer Institute.
  • Ito Y; Department of Cancer Epidemiology, Cancer Control Center, Osaka International Cancer Institute.
J Epidemiol ; 28(10): 420-427, 2018 Oct 05.
Article em En | MEDLINE | ID: mdl-29479003
ABSTRACT

BACKGROUND:

Recent improvements in 5-year survival of breast cancer have been reported in Japan and other countries. Though the number of long-term breast cancer survivors has been increasing, recent improvements in 10-year survival have not been reported. Moreover, the degree of improvement according to age and disease stage remains unclear.

METHODS:

We calculated long-term survival using data on breast cancer diagnosed from 1993 through 2006 from six prefectural population-based cancer registries in Japan. The recent increase in 10-year relative survival was assessed by comparing the results of period analysis in 2002-2006 with the results of cohort analysis in 1993-1997. We also conducted stratified analyses by age group (15-34, 35-49, 50-69, and 70-99 years) and disease stage (localized, regional, and distant).

RESULTS:

A total of 63,348 patients were analysed. Ten-year relative survival improved by 2.4% (76.9% vs 79.3%) from 1993 through 2006. By age and stage, 10-year relative survival clearly improved in the age 35-49 years (+2.9%; 78.1% vs 81.0%), 50-69 years (+2.8%; 75.2% vs 78.0%) and regional disease (+3.4%; 64.9% vs 68.3%). In contrast, the degree of improvement was small in the age 15-34 years (+0.1%; 68.2% vs 68.3%), 70-99 years (+1.0%; 87.6% vs 88.6%), localized disease (+1.1%; 92.6% vs 93.7%) and distant metastasis (+0.9%; 13.8% vs 14.7%).

CONCLUSIONS:

These population-based cancer registry data show that 10-year relative survival improved 2.4% over this period in Japan. By age and stage, improvement in the age 15-34 years and distant metastasis was very small, which suggests the need for new therapeutic strategies in these patients.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Sobreviventes de Câncer País/Região como assunto: Asia Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Sobreviventes de Câncer País/Região como assunto: Asia Idioma: En Ano de publicação: 2018 Tipo de documento: Article